RevealDx Receives FDA Clearance for AI Powered Lung Nodule Risk Assessment
recent articles
FUKUOKA, Japan, Sept. 12, 2023 /PRNewswire/ -- Medmain Inc. (https://en.medmain.com), a Japanese medtech startup that offers PidPort, an AI-powered cloud system to assist in digital pathology, is pleased to announce that it has been selected...
PRINCETON, NJ and DUBLIN, IRELAND / ACCESSWIRE / September 14, 2023 / Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in unified cloud software solutions for regulated...
Corista announces first webinar in three-part series. Imaging Standardization in Digital Pathology and What You Need to Know 3-part series October 18 | 10AM PT / 1PM ET Webinar Details: Title: DICOM in Pathology— Part 1 Imaging...
September 11th, 2023 – Paris, France – Owkin and Tribun Health announce a strategic partnership to advance the development and global deployment of Artificial Intelligence (AI) Diagnostic and Research solutions for pathology...
Deep Bio: An artificial intelligence-based prostate cancer diagnosis aid developed by a Korean company has received marketing authorization from overseas regulators, attracting the industry’s attention. Deep Bio said Tuesday that its...
Ibex: Developed in Collaboration with AstraZeneca and Daiichi Sankyo, Galen™ Breast HER2 Aids Pathologists with Reproducible HER2 Assessment TEL AVIV, Israel, Sept. 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in...
